Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

America Great Health logo
AAGH

America Great Health

MaveScore 31 Low model confidence
Last Price US$0.00 As of Jun 15, 2026
Market Cap US$4.2m Company size context
7D Performance 100.00% Past 7 days
1Y Performance -60.00% Past 12 months
Model Rating
Historical model output for research review

Fundamental data date

Jun 30, 2025

351 days old

Market price date

Jun 15, 2026

1 day old

Coverage

13/16

3 missing model inputs

Data quality

Review

Partial or delayed snapshot

Transparent research score

Why the model scores this stock

MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

MaveScore 31 Low confidence

Stored data quality

Freshness and coverage checks

Stored company inputs are available, but some dates or model fields are older or incomplete.

13/16 Partial or delayed snapshot

Quality

Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.

7/35 Weak

Financial Strength

Financial strength rewards durable profitability, margins, and positive free cash flow.

9/25 Weak

Valuation Support

Valuation needs price plus per-share earnings, cash-flow, or book-value inputs.

0/15 Needs Data

Momentum

Momentum highlights research candidates with supportive 3-month and 6-month price regimes.

15/15 Strong

Shareholder Alignment

Shareholder alignment rewards less dilutive share behavior and enough size for liquid research coverage.

0/10 Weak

Positive model output

  • Momentum highlights research candidates with supportive 3-month and 6-month price regimes.

Research risks to review

  • Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.
  • Financial strength rewards durable profitability, margins, and positive free cash flow.
  • Valuation needs price plus per-share earnings, cash-flow, or book-value inputs.

MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting. Missing inputs right now include free cash flow per share, book value per share, earnings per share.

Dashboard Funda..tals Deep..lue Prediction Screener Map

America Great Health Overview

Industry: Biotechnology

Sector: Healthcare

America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and the manufacturing and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health was founded in 2013 and is headquartered in Alhambra, California.

America Great Health is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review America Great Health in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



America Great Health Competitors

America Great Health operates in the Biotechnology industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

America Great Health

US$0.00

US$4.2m

100.00%

-60.00%